Actively Recruiting
Enhancing Renal Graft Function During Donor Anesthesia
Led by Nazmy Edward Seif · Updated on 2026-01-12
60
Participants Needed
1
Research Sites
414 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Renal transplantation is now recognized as the treatment of choice for patients with end-stage renal disease. An optimum anesthetic regimen should enhance the function and perfusion of the transplanted kidney. The aim of this study is to assess \& compare the effectiveness of 3 different modalities in this respect: Mannitol, Dopamine and adequate hydration.
CONDITIONS
Official Title
Enhancing Renal Graft Function During Donor Anesthesia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults with end-stage renal disease scheduled for living-donor kidney transplantation
You will not qualify if you...
- Severe heart or liver dysfunction
- Blood clotting disorders (coagulopathy)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kasr Al-Ainy Hospital, Cairo University
Cairo, Egypt
Actively Recruiting
Research Team
N
Nazmy E Seif, MD
CONTACT
A
Ahmed M Elbadawy, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here